The stock price of Eli Lilly has seen a rise of 15% over the last month, while it is up 6% in a week. There are a couple of factors that fueled this growth. First, the company recently reported its Q3 results with revenue of $6.8 billion, beating the consensus estimate of $6.6 billion, but earnings
The stock price of Eli Lilly has seen a rise of 15% over the last month, while it is up 6% in a week. There are a couple of factors that fueled this growth. First, the company recently reported its Q3 results with revenue of $6.8 billion, beating the consensus estimate of $6.6 billion, but earnings
Share this Article
Recommended